X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6597) 6597
Publication (353) 353
Newsletter (194) 194
Book Review (94) 94
Newspaper Article (92) 92
Magazine Article (81) 81
Book Chapter (31) 31
Book / eBook (4) 4
Conference Proceeding (4) 4
Trade Publication Article (3) 3
Dissertation (2) 2
Data Set (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5369) 5369
female (2743) 2743
male (2620) 2620
adult (2006) 2006
index medicus (1912) 1912
middle aged (1879) 1879
stomatitis (1681) 1681
aged (1358) 1358
stomatitis - chemically induced (1208) 1208
oncology (1143) 1143
cancer (1003) 1003
chemotherapy (983) 983
animals (973) 973
stomatitis, aphthous - drug therapy (937) 937
stomatitis - etiology (875) 875
stomatitis - drug therapy (836) 836
adolescent (729) 729
care and treatment (664) 664
dentistry, oral surgery & medicine (648) 648
treatment outcome (622) 622
child (602) 602
antineoplastic agents - adverse effects (577) 577
recurrence (535) 535
research (516) 516
vesicular stomatitis-virus (516) 516
stomatitis - prevention & control (514) 514
mucositis (502) 502
health aspects (494) 494
therapy (493) 493
dentistry (485) 485
radiotherapy (458) 458
oral mucositis (455) 455
mice (386) 386
prevention (383) 383
neoplasms - drug therapy (371) 371
analysis (361) 361
antineoplastic combined chemotherapy protocols - adverse effects (352) 352
child, preschool (351) 351
antineoplastic combined chemotherapy protocols - therapeutic use (341) 341
aged, 80 and over (327) 327
viruses (325) 325
clinical trials (315) 315
mouth mucosa - drug effects (314) 314
risk factors (309) 309
double-blind method (306) 306
immunology (304) 304
drug therapy (302) 302
pharmacology & pharmacy (300) 300
mouth mucosa - pathology (290) 290
head and neck neoplasms - radiotherapy (289) 289
management (288) 288
time factors (282) 282
stomatitis - pathology (272) 272
medicine, research & experimental (263) 263
patients (262) 262
stomatitis - therapy (257) 257
surgery (249) 249
diagnosis, differential (247) 247
stomatitis, herpetic - drug therapy (243) 243
mouth mucosa (237) 237
radiotherapy - adverse effects (237) 237
dermatology (235) 235
medicine & public health (234) 234
prospective studies (234) 234
medical research (233) 233
toxicity (233) 233
transplantation (233) 233
clinical trials as topic (231) 231
stomatitis, aphthous - etiology (230) 230
antineoplastic agents - therapeutic use (227) 227
administration, topical (225) 225
infant (225) 225
medicine (225) 225
drug administration schedule (224) 224
young adult (224) 224
double-blind (222) 222
administration, oral (215) 215
follow-up studies (214) 214
head (214) 214
hematology (214) 214
virology (213) 213
medicine, general & internal (212) 212
infections (211) 211
microbiology (211) 211
infection (204) 204
stomatitis, aphthous (204) 204
pain (203) 203
dose-response relationship, drug (202) 202
diagnosis (201) 201
cancer therapies (199) 199
biotechnology & applied microbiology (198) 198
radiation (195) 195
combined modality therapy (192) 192
fluorouracil - administration & dosage (192) 192
fluorouracil - adverse effects (192) 192
trial (190) 190
pediatrics (188) 188
head and neck neoplasms - drug therapy (187) 187
quality of life (186) 186
recurrent aphthous stomatitis (186) 186
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6080) 6080
German (231) 231
Japanese (148) 148
French (146) 146
Russian (123) 123
Italian (67) 67
Spanish (58) 58
Chinese (47) 47
Polish (46) 46
Hungarian (17) 17
Danish (14) 14
Portuguese (12) 12
Romanian (11) 11
Bulgarian (10) 10
Croatian (8) 8
Finnish (7) 7
Czech (6) 6
Turkish (6) 6
Dutch (5) 5
Norwegian (5) 5
Korean (4) 4
Swedish (4) 4
Greek (3) 3
Thai (3) 3
Hebrew (2) 2
Slovak (2) 2
Serbian (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 89, Issue 4, pp. 846 - 853
Background We report the first clinical experience and toxicity of multifield optimization (MFO) intensity modulated proton therapy (IMPT) for patients with... 
Radiology | Hematology, Oncology and Palliative Medicine | PHOTON | RADIOTHERAPY | ONCOLOGY | CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | RADIATION-THERAPY | Uncertainty | Follow-Up Studies | Humans | Middle Aged | Proton Therapy - adverse effects | Male | Carcinoma, Squamous Cell - radiotherapy | Chemoradiotherapy | Radiotherapy, Intensity-Modulated - adverse effects | Tongue Neoplasms - drug therapy | Nasopharyngeal Neoplasms - radiotherapy | Adult | Female | Radiotherapy Setup Errors | Nasopharyngeal Neoplasms - drug therapy | Radiotherapy Planning, Computer-Assisted | Tongue Neoplasms - radiotherapy | Radiotherapy Dosage | Carcinoma, Adenoid Cystic - drug therapy | Oropharyngeal Neoplasms - drug therapy | Radiotherapy, Intensity-Modulated - methods | Head and Neck Neoplasms - drug therapy | Oropharyngeal Neoplasms - radiotherapy | Stomatitis - etiology | Quality Assurance, Health Care | Head and Neck Neoplasms - radiotherapy | Pilot Projects | Carcinoma, Squamous Cell - drug therapy | Aged | Carcinoma, Adenoid Cystic - radiotherapy | Proton Therapy - methods | Xerostomia - etiology | Head and neck tumors | Sects | Care and treatment | Nuclear radiation | Index Medicus | HEAD | MEV RANGE 10-100 | PATIENTS | CLINICAL TRIALS | PROTON BEAMS | SKULL | TOXICITY | MEV RANGE 100-1000 | PLANNING | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | OPTIMIZATION | NECK
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2012, Volume 366, Issue 6, pp. 520 - 529
Resistance to hormone therapy through activation of cellular pathways involving mTOR can develop in postmenopausal hormone-receptor–positive breast cancer.... 
TRIAL | WOMEN | MEDICINE, GENERAL & INTERNAL | EFFICACY | TAMOXIFEN | PHASE-III | LETROZOLE | SUPERIOR | AROMATASE INHIBITORS | FIRST-LINE THERAPY | ANASTROZOLE | Recurrence | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Bone Neoplasms - secondary | TOR Serine-Threonine Kinases - antagonists & inhibitors | Aromatase Inhibitors - adverse effects | Breast Neoplasms - chemistry | Aged, 80 and over | Postmenopause | Adult | Female | Aromatase Inhibitors - therapeutic use | Everolimus | Sirolimus - adverse effects | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Kaplan-Meier Estimate | Receptor, Epidermal Growth Factor - analysis | Breast Neoplasms - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Stomatitis - chemically induced | Aged | Androstadienes - therapeutic use | Androstadienes - adverse effects | Drugs | Care and treatment | Usage | Hormone therapy | Patient outcomes | Drug utilization | Breast cancer | Product/Service Evaluations | Drug therapy, Combination | Drug therapy | TOR protein | Anastrozole | Endocrine therapy | Fatigue | Intracellular signalling | Rapamycin | Tamoxifen | Cancer therapies | Survival | Post-menopause | Fulvestrant | Signal transduction | Stomatitis | Hyperglycemia | Chemotherapy | Pneumonitis | Dyspnea | Aromatase | Antitumor activity | Respiration
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 17, pp. 1609 - 1618
In patients with metastatic colon cancer, fluorouracil, oxaliplatin, and irinotecan plus bevacizumab, as compared with fluorouracil and irinotecan plus... 
1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | INFUSIONAL FLUOROURACIL | LEUCOVORIN | MANAGEMENT | PHASE-III | GUIDELINES | IRINOTECAN | OXALIPLATIN | CHEMOTHERAPY | FOLFIRI | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Bevacizumab | Fluorouracil - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Neoplasm Metastasis - drug therapy | Colorectal Neoplasms - drug therapy | Adult | Female | Leucovorin - therapeutic use | Liver Neoplasms - secondary | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Camptothecin - therapeutic use | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Colorectal Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Treatment outcome | Care and treatment | Analysis | Colorectal cancer | Dosage and administration | Leucovorin | Fluorouracil | Colorectal carcinoma | Diarrhea | Metastasis | Survival | Patients | Clinical outcomes | Metastases | Irinotecan | Stomatitis | Chemotherapy | Neurotoxicity | Oxaliplatin | Monoclonal antibodies | Vascular endothelial growth factor | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 2004, Volume 100, Issue 9, pp. 1995 - 2025
Journal Article
Cancer, ISSN 0008-543X, 2014, Volume 120, Issue 10, pp. 1453 - 1461
BACKGROUND Mucositis is a highly significant, and sometimes dose-limiting, toxicity of cancer therapy. The goal of this systematic review was to update the... 
gastrointestinal | mucositis | guidelines | oral | stomatitis | Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) | HEAD | GASTROINTESTINAL MUCOSITIS | ISOO | CELL TRANSPLANTATION | RANDOMIZED-TRIAL | ZINC SUPPLEMENTATION | NECK-CANCER | ONCOLOGY | MUCOSAL INJURY | ORAL MUCOSITIS | DOUBLE-BLIND | LEVEL LASER THERAPY | Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC | Sucralfate - administration & dosage | Humans | Radiotherapy - adverse effects | Antineoplastic Agents - administration & dosage | Protective Agents - therapeutic use | Mucositis - prevention & control | Proctitis - prevention & control | Antineoplastic Agents - adverse effects | Anti-Inflammatory Agents - therapeutic use | Neoplasms - radiotherapy | Intercellular Signaling Peptides and Proteins - administration & dosage | Low-Level Light Therapy | Esophagitis - therapy | Analgesics - therapeutic use | Proctitis - therapy | Anti-Infective Agents - therapeutic use | Evidence-Based Medicine | Mucositis - therapy | Cytokines - administration & dosage | Esophagitis - etiology | Stomatitis - etiology | Mucositis - chemically induced | Oral Hygiene | Anti-Ulcer Agents - administration & dosage | Neoplasms - drug therapy | Phototherapy | Stomatitis - therapy | Proctitis - etiology | Mucositis - etiology | Stomatitis - chemically induced | Esophagitis - prevention & control | Radiation-Protective Agents - therapeutic use | Stomatitis - prevention & control | Amifostine - therapeutic use | Cryotherapy | Hyperbaric Oxygenation | Practice guidelines (Medicine) | Usage | Care and treatment | Mucositis | Analysis | Cancer | Index Medicus | Abridged Index Medicus | Review
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9808, pp. 2005 - 2012
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 8, pp. 809 - 818
Journal Article